Use of Remdesivir in Patients with SARS-CoV-2 Pneumonia in a Real-Life Setting during the Second and Third COVID-19 Epidemic Waves

In this retrospective comparative study, we evaluated the effectiveness of remdesivir (RDSV) in patients with SARS-CoV-2 pneumonia. Individuals hospitalized between March 2020 and August 2022 at S.M. Goretti Hospital, Latina, with a positive test for SARS-CoV-2 and, concomitantly, pneumonia, were in...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Raffaella Marocco, Cosmo Del Borgo, Eeva Tortellini, Silvia Garattini, Anna Carraro, Daniela Di Trento, Andrea Gasperin, Alessandra Grimaldi, Tiziana Tieghi, Valeria Belvisi, Blerta Kertusha, Mariasilvia Guardiani, Paola Zuccalà, Danilo Alunni Fegatelli, Alessandra Spagnoli, Miriam Lichtner, LATINA COVID-group
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2023-04-01
סדרה:	Viruses
נושאים:	remdesivir SARS-CoV-2 antiviral therapy COVID-19 real-life study
גישה מקוונת:	https://www.mdpi.com/1999-4915/15/4/947
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!